Literature DB >> 7849875

A longitudinal study of prenatal marijuana use. Effects on sleep and arousal at age 3 years.

R E Dahl1, M S Scher, D E Williamson, N Robles, N Day.   

Abstract

OBJECTIVE: To test the hypothesis that sleep disruptions would be evident in 3-year-old children with a history of prenatal marijuana exposure.
DESIGN: A prospective study using stratified random sampling beginning in the fourth month of pregnancy. Marijuana and other substance use were assessed by interviews at multiple time points. Offspring were followed up through age 3 years with multidomain assessments at fixed time points, including electroencephalographic sleep studies in the newborn period and at age 3 years.
SETTING: Primary care, prenatal clinic at a university hospital.
SUBJECTS: The sample included 18 children with prenatal marijuana exposure (mean [+/- SD] age, 39.0 +/- 4.4 months) and 20 control children (mean [+/- SD] age, 39.7 +/- 4.4 months). The two groups were similar in relationship to maternal age, race, income, education, or maternal use of alcohol, nicotine, and other substances in the first trimester. MAIN OUTCOME MEASURE: Sleep variables from polysomnographic recordings at age 3 years.
RESULTS: Children with prenatal marijuana exposure showed more nocturnal arousals (mean [+/- SD], 8.2 +/- 5.3 vs 3.2 +/- 4.6; P < .003), more awake time after sleep onset (mean [+/- SD], 27.4 +/- 20.0 vs 13.7 +/- 12.4 min; P < .03), and lower sleep efficiency (mean [+/- SD], 91.0 +/- 3.8 vs 94.4 +/- 2.1; P < .03) than did control children.
CONCLUSION: Prenatal marijuana exposure was associated with disturbed nocturnal sleep at age 3 years.

Entities:  

Mesh:

Year:  1995        PMID: 7849875     DOI: 10.1001/archpedi.1995.02170140027004

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  22 in total

1.  Sleep problems in children with prenatal substance exposure: the Maternal Lifestyle study.

Authors:  Kristen C Stone; Linda L LaGasse; Barry M Lester; Seetha Shankaran; Henrietta S Bada; Charles R Bauer; Jane A Hammond
Journal:  Arch Pediatr Adolesc Med       Date:  2010-05

Review 2.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

Review 3.  Cannabis use during pregnancy: Pharmacokinetics and effects on child development.

Authors:  Kimberly S Grant; Rebekah Petroff; Nina Isoherranen; Nephi Stella; Thomas M Burbacher
Journal:  Pharmacol Ther       Date:  2017-08-25       Impact factor: 12.310

4.  Prevalence and correlates of a lifetime cannabis use disorder among pregnant former tobacco smokers.

Authors:  Rebecca L Emery; Melissa P Gregory; Jennifer L Grace; Michele D Levine
Journal:  Addict Behav       Date:  2015-12-15       Impact factor: 3.913

Review 5.  It's not your mother's marijuana: effects on maternal-fetal health and the developing child.

Authors:  Tamara D Warner; Dikea Roussos-Ross; Marylou Behnke
Journal:  Clin Perinatol       Date:  2014-09-27       Impact factor: 3.430

6.  Effects of prenatal exposure to marijuana.

Authors:  E Kozer; G Koren
Journal:  Can Fam Physician       Date:  2001-02       Impact factor: 3.275

7.  The effects of prenatal marijuana exposure on delinquent behaviors are mediated by measures of neurocognitive functioning.

Authors:  Nancy L Day; Sharon L Leech; Lidush Goldschmidt
Journal:  Neurotoxicol Teratol       Date:  2011 Jan-Feb       Impact factor: 3.763

8.  Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain.

Authors:  Chia-Shan Wu; Christopher P Jew; Hui-Chen Lu
Journal:  Future Neurol       Date:  2011-07-01

9.  Longitudinal study of maternal report of sleep problems in children with prenatal exposure to cocaine and other drugs.

Authors:  Kristen C Stone; Pamela C High; Cynthia L Miller-Loncar; Linda L Lagasse; Barry M Lester
Journal:  Behav Sleep Med       Date:  2009       Impact factor: 2.964

Review 10.  Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions.

Authors:  Luca Ferraro; M C Tomasini; S Beggiato; S Gaetani; T Cassano; V Cuomo; S Amoroso; S Tanganelli; T Antonelli
Journal:  J Neural Transm (Vienna)       Date:  2009-05-12       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.